Navigation Links
Catalyst Pharmaceutical Partners, Inc. Begins Enrollment for U.S. Phase II Clinical Trial of CPP-109 in Patients with Methamphetamine Addiction
Date:6/30/2008

CORAL GABLES, Fla., June 30 /PRNewswire-FirstCall/ -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq: CPRX), a biopharmaceutical company that acquires or in-licenses, develops and commercializes prescription drugs for the treatment of drug addiction and obsessive compulsive disorders, today announced that it has begun enrollment for its randomized, double-blind, placebo-controlled U.S. Phase II clinical trial evaluating CPP-109 for the treatment of patients addicted to methamphetamine. CPP-109, an orally administered, small molecule drug which inhibits psychostimulant-induced dopamine release, is Catalyst's version of vigabatrin.

In April 2008, Catalyst held a kick-off training meeting in Scottsdale, Arizona with the clinical investigators and study coordinators who will conduct the trial. Approximately 40 attendees, including clinicians and staff representing 15 clinical trial sites, attended the meeting. Catalyst expects to immediately begin screening patients for inclusion in this trial and expects initial top-line results of the Phase II clinical trial to be available during the summer of 2009.

Catalyst's web site http://www.catalystpharma.com includes a listing of the CPP-109 study sites and relevant contact information. For more information about enrolling in this study, please contact the study sites directly. Additional detailed information about the trial will soon be available on http://www.clinicaltrials.gov (search for Catalyst).

Patrick J. McEnany, Chief Executive Officer of Catalyst, commented, "We are excited to follow up on our cocaine trial with the initiation of our second, large-scale
'/>"/>

SOURCE Catalyst Pharmaceutical Partners, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Catalyst Pharmaceutical Partners Begins Enrollment for Its U.S. Phase II Clinical Trial of CPP-109 in Patients with Cocaine Addiction
2. Catalyst Pharmaceutical Partners Reports Fourth Quarter and Year-End 2007 Financial Results
3. Catalyst Biosciences Selects Drug Development Candidate in Factor VIIa Program for Hemophilia
4. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
5. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
6. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
7. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
8. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
9. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
10. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
11. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... 22, 2013  Milliman, Inc., a premier global consulting ... 2013 Milliman Medical Index (MMI), which measures the healthcare ... healthcare benefits through an employer-sponsored preferred provider organization (PPO) ... in 2013 is $22,030. "For the ... on a percentage basis was the lowest in the ...
(Date:5/22/2013)... PRINCETON, New Jersey , 22. Mai ... Unternehmen für Fähigkeitsentwicklung und Beratung, gab heute ... Chris Geraghty , zum ... als 20 Jahre im Industriebereich wo er ... die Nachfolge von Ray Baxter an, der ...
(Date:5/22/2013)... STEPh, Inc., a full service medical communications ... web site ( http://www.stephreports.com ) dedicated to ... STEPh Reports STEPh Reports are comprehensive critical ... STEPh Report assesses the competitive landscape by individual drug ... and specific key issues.  STEPh Reports are written by ...
Breaking Medicine Technology:Annual Healthcare Cost for a Typical American Family is $22,030 According to 2013 Milliman Medical Index 2Kepner-Tregoe, Inc. befördert Chris Geraghty zum Hauptgeschäftsführer 2Kepner-Tregoe, Inc. befördert Chris Geraghty zum Hauptgeschäftsführer 3Scientific and Technical Evaluation of Pharmaceuticals, Inc. [STEPh, Inc.], Launches New Competitive Intelligence Web Site 2
... Everyone knows where to look for the medications that you ... have proven to be a reliable source for medication but ... the right generic Viagra merchant? www.rx-webmasters.com ... over the world. Through years of successful and prosperous development, ...
... Management, a full-service Contract Research Organization providing expertise in ... changing its name to ClinicalRM to support the company,s ... providers of clinical trial and research services for both ... with the name change, ClinicalRM is also launching a ...
Cached Medicine Technology:Rx-webmasters.com is Your Number One Choice for Affordable Medications 2Clinical Research Management, a Full-Service CRO, Changes Its Name to ClinicalRM 2
(Date:5/22/2013)... The health care crisis in the United States is ... percent of all adults are without health insurance. Further, ... U.S. are related to medical bills. The high price ... patients cannot afford to take their prescriptions as directed by ... That's why MedicationDiscountCard.com is offering savings of up to seventy-five ...
(Date:5/22/2013)... 2013 NBA Draft tickets go on sale to the ... The 2013 NBA Draft will be held at the new Barclays ... Nets. The Barclays Center has already become a mecca for ... Paul McCartney and Beyonce have already booked sold out concerts at ... perform at this state-of-the-art venue. Disney on Ice will also ...
(Date:5/22/2013)... May 22, 2013 Abadir Associates, a ... treatments for optimal results, is offering a new technique ... neck. The practice has successfully treated multiple patients ... “Basically, this approach is for women who want to ... dermatologist Dr. Michelle Abadir of Abadir Associates. ...
(Date:5/22/2013)... - May 22 2013: New research shows that ... in specific regions of the brain that are ... planning actions and in motivation. Dr. Alain ... these decision-making brain regions could underlie addiction. These ... Meeting, the annual meeting of the Canadian Association ...
(Date:5/22/2013)... By Dennis Thompson HealthDay Reporter , , TUESDAY, ... Americans isn,t improving much, with about six in 10 ... in unhealthy behaviors like smoking, heavy drinking or not ... Tuesday by the U.S. Centers for Disease Control and ... of the lifestyle choices that have led to soaring ...
Breaking Medicine News(10 mins):Health News:Lyrica Discount Cards Now Available From MedicationDiscountCard.com 2Health News:2013 NBA Draft Tickets: Cheap Concert Tickets Announces that Official Onsales for the 2013 NBA Draft Begin at 10:00 am Local Time on Wednesday, May 22, 2013 2Health News:Westchester Dermatologist Abadir Associates Offers New Neck Lift Surgery Alternative 2Health News:Addiction as a disorder of decision-making 2Health News:Americans Still Making Unhealthy Choices: CDC 2Health News:Americans Still Making Unhealthy Choices: CDC 3
... Researchers at Moffitt Cancer Center have placed new emphasis on ... treatment and survivorship. Their focus is on gathering and using ... life for patients in treatment and for cancer survivors. ... carried out by researchers in Moffitt,s Department of Health Outcomes ...
... The incidence of babies with irregular head shapes, such as ... increased in the United States since the Back to Sleep ... syndrome, an expert says. "There,s no doubt that as ... their backs, the incidence of [sudden infant death syndrome] declined ...
... Moores Professor of Psychology, has earned the University of ... overall career excellence and the highest honor UH bestows ... cash prize of $10,000. "The Farfel Award is ... may have as professionals, as mentors, teachers, scholar/researchers, clinicians ...
... -- Two genetic variations are linked to a common form ... research. Glaucoma affects about 2.2 million people in the ... news release. "Loss of vision from glaucoma, a common ... the optic nerve," noted one expert, Dr. Mark Fromer, an ...
... Sheffield have defined the structure of a key part of ... of body fat- which could help provide new treatments for ... in research, published in the journal Structure , will ... block and stimulate the receptor for the obesity hormone leptin. ...
... , FRIDAY, April 27 (HealthDay News) -- Children who are ... the time they are 12 years old, according to a new ... and the United Kingdom said its findings, published online April 27 ... risk for this type of behavior. Examples of self-harming ...
Cached Medicine News:Health News:Moffitt Cancer Center researchers: Quality of life as important as quantity of life 2Health News:Moffitt Cancer Center researchers: Quality of life as important as quantity of life 3Health News:More Babies Today Have Irregular Head Shape: Expert 2Health News:Neuropsychologist receives University of Houston's highest faculty honor 2Health News:Neuropsychologist receives University of Houston's highest faculty honor 3Health News:Research Gets Closer to Genetic Roots of Glaucoma 2Health News:New drug to tackle fat problems 2Health News:Bullied Children at Greater Risk for Self-Harm, Study Finds 2
Inquire...
Sealing Mat for 384-well, Square Well Plates Available Sterile...
96-well Silicone Expansion Mat, Bulk...
Microseal 'M' mats, seals 96-well plates, reusable, pkg of 10...
Medicine Products: